doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: d cold

1 - 4 of 4 <<previous | next>>

Drugs results:

Cetirizine pills

Cetirizine

Cetirizine is in a class of drug known as an antihistamine also called anti-pruritic. Pruritus is a medical term which means itchiness. Cetirizine blocks the actions of the naturally occurring chemical substance histamine in the body. Histamine is rele more...

Naprosyn

Naprosyn

In 1976, Naprosyn was introduced as a non-steroidal anti-inflammatory drug, commonly referred to as NSAIDs. It hit the market as a prescription only drug, and in most cases it still is. Low dose Naprosyn is available in Australia, and low dose form more...

Clomipramine

Clomipramine

As with all tricyclic antidepressants, Clomipramine carries a wide range of side effects and potential drug interactions. Patients are encouraged to notify their doctor of all related side effects they experience as well as discuss even subtle chan more...

Tofranil pills

Tofranil

Tofranil is a member of the tricyclic family of psychotropic medications designed to treat serious disorders that cause harm to the patient. Behaviors such as cutting, self burning, self mutilation, and hair pulling are all disorders that can benefit from more...

Diseases results:

Hives
Bursitis
Mental Health and Depression
Bronchitis
Emphysema
Migraine headaches

Articles results:

UCL And Sewon Cellontech To Work On Delivery Of Orthopaedic Treatments Using Stem Cell Therapies
UCL Business plc and the Royal National Orthopaedic Hospital NHS Trust (RNOH) have signed an agreement with Sewon Cellontech (SC) of South Korea to collaborate on new laboratories that will develop clinical cell therapeutic treatments for cartilage repair and bone fracture healing. The techniques use stem cells derived from the patient's own bone marrow and cartilage tissue with the potential to alleviate the need for radical surgery.


FDA Takes Action To Stop Marketing Of Unapproved Timed-Release Guaifenesin Drug Products
The U.S. Food and Drug Administration (FDA) today announced its intention to take action against companies that market unapproved drug products in timed-release dosage form that contain guaifenesin, a substance commonly used in medicines to relieve cough and cold symptoms by stimulating removal of mucous from the lungs.




1 - 4 of 4 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.